This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinicaltrial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
The Top Medical Cannabis Research of 2017 A word from Ron Lipsky, Manager of Business Development and International Relations at MGC Pharmaceuticals MGC Pharma is still riding off the success of 2017 as we progress into 2018, with many exciting developments on the horizon.
The study, titled Pharmacokinetics, efficacy, and safety of a novel selective-dose cannabis inhaler in patients with chronicpain: A randomized, double-blinded, placebo-controlled trial , was first published by NORML. “The 1mg dose showed a significant pain decrease compared to the placebo.
The cannabis plant has been used medicinally for a multitude of health issues, specifically chronicpain. The use of cannabis has been well-documented throughout historical and ancient times and well supported through the medical literature. Modern medical marijuana genetics are more prolific and stronger than ever before.
It’s hard to get past decades of federal prohibition and criminalization, so it’s little wonder that in 2017 only three percent of adults over 65 years old reported being “current smokers.” [1]. Numerous studies point to that fact, especially in cases surrounding chronicpain and discomfort. Why is that important? Hill, Kevin P.,
That is, until a “forward-thinking” primary care physician suggested medical cannabis for his chronicpain, which Gresh, 54, said set him on a new path that has changed his life for the better and helped him stop using virtually all drugs classified as highly addictive. . “I I never thought that would have been possible,” he said. “I
Similar to ketamine, psilocybin has shown great promise in clinicaltrials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.
DoobTool was created in Halifax, Nova Scotia in 2017, with the “active cannabis consumer in mind” and the goal of “breaking through the stoner stereotypes,” according to the company website. Will the DoobTool make you feel like a survivalist? The Hydrology9 NX: A water vape? Is it a bong? Is it a vaporizer? sorta both?
According to a University of Auckland article on the audit , CBD oil taken for four weeks significantly improved the self-reported quality of life most for patients with non-cancer chronicpain and anxiety-related mental health conditions. New Zealand’s government eased restrictions on cannabidiol in 2017.
Chronicpain. One area that reports looked closely was, use of medical marijuana to treat chronicpain. Chronicpain is a foremost cause of disability that affects more than 25 million adults in the U.S. Chronicpain is a foremost cause of disability that affects more than 25 million adults in the U.S.
Then, in November 2019, the FDA granted the designation to the nonprofit Usona Institute to study psilocybin’s effect on major depressive order, for which clinicaltrials are currently under way. See Usona Institute, A Study of Psilocybin for Major Depressive Disorder (MDD) , ClinicalTrial ID NCT03866174, available at [link].
Drug interactions reported in the scientific literature most often occur at very high doses used in clinicaltrials of epilepsy and other conditions. For example, most statin drugs can cause memory issues, muscle pain, fatigue and muscle weakness. The Journal of Clinical Pharmacology 60.4 2017): 1586-1592.
It’s when presented with personal stories like that of the Rhodes family and the stream of alarming data that the significance of Tetra Bio-Pharma’s (TBP) clinicaltrials is worth exploring. Can medical cannabis be the solution? Something needs to be done”: Making medicine attainable and affordable.
As reviewed in a recent Forbes article, “a study of more than 400 health care professionals has revealed that most physicians lack knowledge of medicinal cannabis, with 65% saying that they have been asked about medical marijuana as a treatment for chronicpain but were unable to answer their patients’ questions” (1).
In fact, at the beginning of 2017, the United States National Academy of Sciences published a report where they analysed the efficacy of cannabis and classified its use as “ effective medicine “ This is because CBD is successful against various pathologies. Use of cannabidiol (CBD) for the treatment of chronicpain.
As yet there have been no FDA -approved clinicaltrials to determine the efficacy of CBD -rich cannabis oil extracts for traumatic brain injury. Writing in 2017, Mayo Clinic neurologist Eugene L. CBD produces no intoxicating effects, no THC -like high, and its use does not lead to tolerance. A promiscuous compound.
Poirier sued following a surgical procedure that left her with chronicpain and limitations affecting her lifestyle and career. Following the incident, Poirier was prescribed numerous medications, but at the time of trial, she was only taking a muscle relaxant and cannabis. Robichaud 4. Siegrist with approval. ” 42.
We’re not going to get over the fact that there’s not the same sort of clinicaltrial and that type of evidence for cannabis and cannabis treatments in the very near future for various reasons. There’s the one drug, one target, cannabis is multiple active ingredients and acts on multiple targets in the body.
Chronicpain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. Yet, patient-reported use of medicinal cannabis for pain, anxiety, and depression is high (Kosiba et al. Conclusions. Full size image.
Drug interactions reported in the scientific literature most often occur at very high doses used in clinicaltrials of epilepsy and other conditions.[1]. For example, most statin drugs can cause memory issues, muscle pain, fatigue and muscle weakness. The Journal of Clinical Pharmacology 60.4 2017): 1586-1592. [7]
Some people turn to cannabis to help them manage the symptoms of mild pain and inflammation. Others use cannabis to help manage chronicpain. ” The review also found that synthetic cannabinoids such as nabilone may help reduce nightmares associated with PTSD and potentially improve sleep among patients with chronicpain.
Similar to ketamine, psilocybin has shown great promise in clinicaltrials for helping to effectively treat depression and PTSD (and we’ve written about psilocybin several times on this blog, including here and here ). Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.
Many experts believe it can lead to beneficial treatments, reiterated in a report released by the National Academies of Sciences, Engineering, and Medicine in January 2017. Neighboring Peru’s medical cannabis law was passed in 2017 and its basic regulations were published in February 2019.
The National Center for Biotechnology Information has summarized a group of FDA approved randomized clinicaltrials, finding evidence for cannabis as medicine. National Library of Medicine has more than 26,000 published studies/reviews across 24 databases regarding cannabis available to read online.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content